Mayo Clinic has one of the largest and most experienced practices in the United States,
with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work
together to ensure quality care and successful recovery.
Lab research on hepatitis C
Mayo Clinic researchers are studying the ways the hepatitis C virus may respond to treatment.
Note: This content was created prior to the coronavirus disease 2019 (COVID-19) pandemic and does not demonstrate proper pandemic protocols. Please follow all recommended Centers for Disease Control and Prevention guidelines for masking and social distancing.
Mayo Clinic doctors and researchers are studying innovations in the diagnosis and treatment of hepatitis C, with particular emphasis on optimal antiviral therapy before and after liver transplant. Immunologists and virologists are also working on development of a hepatitis C vaccine.
Another area of research is cell transplantation, which involves infusing liver cells, cells much like liver cells or stem cells through the portal vein into the liver or into a peripheral blood vessel to repair liver damage.